Fenretinide inhibits macrophage inflammatory mediators and controls hypertension in spontaneously hypertensive rats via the peroxisome proliferator-activated receptor gamma pathway

References

• LiuJLiJZhangJFXinXYCombination of fenretinide and selenite inhibits proliferation and induces apoptosis in ovarian cancer cellsInt J Mol Sci20131411217902180424192821
   PubMed Web of Science ®Google Scholar
• HolmesWFSopranoDRSopranoKJComparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPRJ Cell Biochem200389226227812704790
   PubMed Web of Science ®Google Scholar
• LachanceCWojewodkaGSkinnerTAGuilbaultCDe SanctisJBRadziochDFenretinide corrects the imbalance between omega-6 to omega-3 polyunsaturated fatty acids and inhibits macrophage inflammatory mediators via the ERK pathwayPLoS One201389e7487524069363
   PubMed Web of Science ®Google Scholar
• KohIUJunHSChoiJSFenretinide ameliorates insulin resistance and fatty liver in obese miceBiol Pharm Bull201235336937522382323
   PubMed Web of Science ®Google Scholar
• OuHYWuHTYangYCWuJSChengJTChangCJElevated retinol binding protein 4 contributes to insulin resistance in spontaneously hypertensive ratsHorm Metab Res201143531231821365528
   PubMed Web of Science ®Google Scholar
• UsudaDKandaTPeroxisome proliferator-activated receptors for hypertensionWorld J Cardiol20146874475425228953
   PubMedGoogle Scholar
• KetsawatsomkronPSigmundCDMolecular mechanisms regulating vascular tone by peroxisome proliferator activated receptor gammaCurr Opin Nephrol Hypertens201524212313025587903
   PubMed Web of Science ®Google Scholar
• NaralaVRSubramaniPANarasimhaVRShaikFBPanatiKThe role of nitrated fatty acids and peroxisome proliferator-activated receptor gamma in modulating inflammationInt Immunopharmacol201423128328725241247
   PubMed Web of Science ®Google Scholar
• AhmadianMSuhJMHahNPPAR gamma signaling and metabolism: the good, the bad and the futureNat Med201319555756623652116
   PubMed Web of Science ®Google Scholar
• ChoiS-SParkJChoiJHRevisiting PPARγ as a target for the treatment of metabolic disordersBMB Reports2014471159960825154720
   PubMed Web of Science ®Google Scholar
• RicoteMGlassCKPPARs and molecular mechanisms of transrepressionBiochim Biophys Acta20071771892693517433773
   PubMed Web of Science ®Google Scholar
• HarrisGGhazallahRANasceneDWuertzBOndreyFGPPAR activation and decreased proliferation in oral carcinoma cells with 4-HPROtolaryngol Head Neck Surg2005133569570116274795
   PubMed Web of Science ®Google Scholar
• HuangCYangYLiWXHyperin attenuates inflammation by activating PPAR-gamma in mice with acute liver injury (ALI) and LPS- induced RAW264.7 cellsInt Immunopharmacol201529244044726526086
   PubMed Web of Science ®Google Scholar
• RangwalaSMLazarMAPeroxisome proliferator-activated receptor gamma in diabetes and metabolismTrends Pharmacol Sci200425633133615165749
   PubMed Web of Science ®Google Scholar
• McIlroyGDDelibegovicMOwenCFenretinide treatment prevents diet-induced obesity in association with major alterations in retinoid homeostatic gene expression in adipose, liver, and hypothalamusDiabetes201362382583623193184
   PubMed Web of Science ®Google Scholar
• LawREGoetzeSXiXPExpression and function of PPAR gamma in rat and human vascular smooth muscle cellsCirculation2000101111311131810725292
   PubMed Web of Science ®Google Scholar
• MarxNSukhovaGMurphyCLibbyPPlutzkyJMacrophages in human atheroma contain PPARγ: differentiation-dependent peroxisomal proliferator-activated receptor γ (PPARγ) expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitroAm J Pathol1998153117239665460
   PubMed Web of Science ®Google Scholar
• HaffnerSMGreenbergASWestonWMChenHWilliamsKFreedMIEffect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitusCirculation2002106667968412163427
   PubMed Web of Science ®Google Scholar
• LeibovitzESchiffrinELPPAR activation: a new target for the treatment of hypertensionJ Cardiovasc Pharmacol200750212012517703128
   PubMed Web of Science ®Google Scholar
• BruemmerDBlaschkeFLawRENew targets for PPAR gamma in the vessel wall: implications for restenosisInt J Obes (Lond)200529Suppl 1S26S30
   PubMedGoogle Scholar
• RicoteMLiACWillsonTMKellyCJGlassCKThe peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activationNature1998391666279829422508
   PubMed Web of Science ®Google Scholar
• LastraGManriqueCPerivascular adipose tissue, inflammation and insulin resistance: link to vascular dysfunction and cardiovascular diseaseHorm Mol Biol Clin Investig20152211926
   PubMedGoogle Scholar
• MacMickingJXieQWNathanCNitric oxide and macrophage functionAnnu Rev Immunol19971513233509143691
   PubMedGoogle Scholar
• BeckmanJSBeckmanTWChenJMarshallPAFreemanBAApparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxideProc Natl Acad Sci U S A1990874162016242154753
   PubMed Web of Science ®Google Scholar
• KimEJKwonKJParkJYLeeSHMoonCHBaikEJEffects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2Brain Res20029411–211012031542
   PubMed Web of Science ®Google Scholar
• SunZAging, arterial stiffness, and hypertensionHypertension201565225225625368028
   PubMed Web of Science ®Google Scholar
• AvendañoMSMartínez-RevellesSAguadoARole of COX-2-derived PGE2 on vascular stiffness and function in hypertensionBr J Pharmacol201617391541155526856544
   PubMed Web of Science ®Google Scholar
• BomfimGFEchemCMartinsCBToll-like receptor 4 inhibition reduces vascular inflammation in spontaneously hypertensive ratsLife Sci20151221725498891
   PubMed Web of Science ®Google Scholar
• DiepQNSchiffrinELIncreased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive ratsHypertension200138224925411509485
   PubMed Web of Science ®Google Scholar